NEU logo

NEU

NewMarket Corp

$742.94
+$1.23(+0.17%)
61
Overall
95
Value
27
Tech
--
Quality
Market Cap
$7.30B
Volume
51.61K
52W Range
$480.00 - $875.97
Target Price
$450.00

Company Overview

Mkt Cap$7.30BPrice$742.94
Volume51.61KChange+0.17%
P/E Ratio15.8Open$743.04
Revenue$2.8BPrev Close$741.71
Net Income$462.4M52W Range$480.00 - $875.97
Div Yield12.00%Target$450.00
Overall61Value95
Quality--Technical27

No chart data available

About NewMarket Corp

NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrain and hydraulic systems, gear oils, hydraulic oils, turbine oils, and other applications where metal-to-metal moving parts are utilized; engine oil additives designed for passenger cars, motorcycles, on and off-road heavy duty commercial equipment, locomotives, and engines in ocean-going vessels; driveline additives designed for products, such as transmission fluids, axle fluids, and off-road powertrain fluids; and industrial additives designed for products for industrial applications consisting of hydraulic fluids, greases, industrial gear fluids, and industrial specialty applications comprising turbine oils. It also provides fuel additives that are used to enhance the oil refining process and the performance of gasoline, diesel, biofuels, and other fuels to industry, government, original equipment manufacturers, and individual customers. In addition, the company engages in the marketing of antiknock compounds, as well as contracted manufacturing and related services; and owns and manages a real property in Virginia. It operates in North America, Latin America, the Asia Pacific, Europe, the Middle East, Africa, India, and internationally. NewMarket Corporation was founded in 1887 and is headquartered in Richmond, Virginia.

Sector: Basic Materials
Industry: Specialty Chemicals

Latest News

Neuren Pharmaceuticals Limited (NURPF) Gets a Buy from Petra Capital

In a report released on November 6, Tanushree Jain from Petra Capital maintained a Buy rating on Neuren Pharmaceuticals Limited, with a price targe...

TipRanks Auto-Generated Intelligence Newsdesk14 days ago

Neuren Pharmaceuticals: Advancing Neurodevelopmental Therapies Amidst Industry Challenges

TipRanks Australian Auto-Generated Newsdesk14 days ago

Neuren Pharmaceuticals Achieves Record DAYBUE™ Sales in Q3 2025

TipRanks Australian Auto-Generated Newsdesk18 days ago

NeuroGenesis’ New Study on NG01: A Potential Game-Changer for SPMS

TipRanks Clinical-Trials-Auto-Generated Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2NEU$742.94+0.2%51.61K
3
4
5
6

Get NewMarket Corp Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.